Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 13

1.

Human metabolites of synthetic cannabinoids JWH-018 and JWH-073 bind with high affinity and act as potent agonists at cannabinoid type-2 receptors.

Rajasekaran M, Brents LK, Franks LN, Moran JH, Prather PL.

Toxicol Appl Pharmacol. 2013 Jun 1;269(2):100-8. doi: 10.1016/j.taap.2013.03.012. Epub 2013 Mar 26.

2.

Distinct pharmacology and metabolism of K2 synthetic cannabinoids compared to Δ(9)-THC: mechanism underlying greater toxicity?

Fantegrossi WE, Moran JH, Radominska-Pandya A, Prather PL.

Life Sci. 2014 Feb 27;97(1):45-54. doi: 10.1016/j.lfs.2013.09.017. Epub 2013 Sep 29. Review.

3.

Metabolism of classical cannabinoids and the synthetic cannabinoid JWH-018.

Su MK, Seely KA, Moran JH, Hoffman RS.

Clin Pharmacol Ther. 2015 Jun;97(6):562-4. doi: 10.1002/cpt.114. Epub 2015 Apr 17. Review.

PMID:
25788107
4.

Moving around the molecule: relationship between chemical structure and in vivo activity of synthetic cannabinoids.

Wiley JL, Marusich JA, Huffman JW.

Life Sci. 2014 Feb 27;97(1):55-63. doi: 10.1016/j.lfs.2013.09.011. Epub 2013 Sep 23. Review.

5.

Cannabinoid CB1 and CB2 receptor ligand specificity and the development of CB2-selective agonists.

Ashton JC, Wright JL, McPartland JM, Tyndall JD.

Curr Med Chem. 2008;15(14):1428-43. Review.

PMID:
18537620
6.

CB2 receptor ligands.

Huffman JW.

Mini Rev Med Chem. 2005 Jul;5(7):641-9. Review.

PMID:
16026310
7.

Synthetic cannabinoids: epidemiology, pharmacodynamics, and clinical implications.

Castaneto MS, Gorelick DA, Desrosiers NA, Hartman RL, Pirard S, Huestis MA.

Drug Alcohol Depend. 2014 Nov 1;144:12-41. doi: 10.1016/j.drugalcdep.2014.08.005. Epub 2014 Aug 18. Review.

8.
9.

The K2/Spice phenomenon: emergence, identification, legislation and metabolic characterization of synthetic cannabinoids in herbal incense products.

Brents LK, Prather PL.

Drug Metab Rev. 2014 Feb;46(1):72-85. doi: 10.3109/03602532.2013.839700. Epub 2013 Sep 24. Review.

10.

Brain cannabinoid receptor 2: expression, function and modulation.

Chen DJ, Gao M, Gao FF, Su QX, Wu J.

Acta Pharmacol Sin. 2017 Mar;38(3):312-316. doi: 10.1038/aps.2016.149. Epub 2017 Jan 9. Review.

11.

Synthetic Pot: Not Your Grandfather's Marijuana.

Ford BM, Tai S, Fantegrossi WE, Prather PL.

Trends Pharmacol Sci. 2017 Mar;38(3):257-276. doi: 10.1016/j.tips.2016.12.003. Epub 2017 Feb 2. Review.

PMID:
28162792
12.

Neuropharmacology of New Psychoactive Substances (NPS): Focus on the Rewarding and Reinforcing Properties of Cannabimimetics and Amphetamine-Like Stimulants.

Miliano C, Serpelloni G, Rimondo C, Mereu M, Marti M, De Luca MA.

Front Neurosci. 2016 Apr 19;10:153. doi: 10.3389/fnins.2016.00153. eCollection 2016. Review.

13.

Critical appraisal of the potential use of cannabinoids in cancer management.

Cridge BJ, Rosengren RJ.

Cancer Manag Res. 2013 Aug 30;5:301-13. doi: 10.2147/CMAR.S36105. eCollection 2013. Review.

Supplemental Content

Support Center